Delivery Order SPE2DB20D1109-SPE2DB25FN37R

Award Date 1/8/25
Potential Completion Date 1/9/25
Potential Value $6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a Firm Fixed Price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,161.02, is for the supply of STELARA 45 MG/0.5 ML SYRINGE 0.5ML, a specialty pharmaceutical product. The award has an ultimate completion date of January 8, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,561.86 firm fixed-price contract is for the supply of STELARA 45 MG/0.5 ML syringes, with a period of performance through November 12, 2024. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor in the United States. The contract, valued at $7,614.58, is for the supply of STELARA 45 MG/0.5 ML SYRINGE 0.5ML, a specialty medication. The contract has an ultimate completion date of August 15, 2024 and is a firm fixed-price delivery order. Amerisourcebergen, through its extensive supply chain network, will provide this...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $29,847.39, is a Firm Fixed Price Delivery Order for the supply of STELARA 45 MG/0.5 ML SYRINGE 0.5ML, a specialty medication. The contract has an ultimate completion date of January 7, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $38,509.13 firm-fixed-price contract is for the supply of STELARA 45 MG/0.5 ML SYRINGE 0.5ML, a specialty medication. The contract has a period of performance through September 10, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of STELARA 45 MG/0.5 ML SYRINGE 0.5ML. The order, valued at $7,222.86, has a firm fixed price and an ultimate completion date of October 18, 2024. The contract is not designated as a set-aside. AmerisourceBergen, as the prime contractor, has an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999...
This is a $7,455.14 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division for the supply of Stelara 90 mg/mL syringes. The contract has an ultimate completion date of April 30, 2024. Amerisourcebergen is a major pharmaceutical distributor that holds a large Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 2025, for a wide range of...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract is for the delivery of STELARA 45 MG/0.5 ML SYRINGE 0.5ML, with a potential value of $62,958.83 and a completion date of February 9, 2024. AmerisourceBergen Drug Corp is the prime contractor and there are no set-aside designations associated...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corporation's Corporate Office division. The contract is for the supply of 4566054668 STELARA 45 MG/0.5 ML SYRINGE 0.5ML, a specialty pharmaceutical product. The contract has a ceiling value of $7,064.46 and a final completion date of October 9, 2024. Amerisourcebergen, a major pharmaceutical distributor, was awarded this delivery order as part of...
This is a $10,778.63 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office division. The order is for the pharmaceutical product STELARA 45 MG/0.5 ML SYRINGE 0.5ML, with a completion date of September 27, 2024. Amerisourcebergen is a major pharmaceutical distributor that holds several Indefinite Delivery Contracts (IDCs) with the DLA and other federal agencies, valued up to $999,999,999, to provide...
  • SPE2DB20D1109
    Indefinite Delivery Contract
  • SPE2DB20D1109-SPE2DB25FN37R
    Delivery Order

This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,988.03, is for the delivery of STELARA 45 MG/0.5 ML SYRINGE 0.5ML, a specialty pharmaceutical product. The contract has an ultimate completion date of January 9, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This delivery order is not designated with a set-aside requirement, indicating open competition.

Generated 4/9/25, 9:49 AM